Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TAIKO PHARMA, Jan-Mar (1Q) Ordinary Profit Decreases by 95%
4574 TAIKO PHARMACEUTICAL CO., LTD. 【J-GAAP】
Earnings ReportTAIKO PHARMACEUTICAL CO., LTD. <4574> [TSE Prime] announced its financial results after the market closed on May 9th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) significantly dropped 95.2% from the same period last year to 11 million yen. The progress rate toward the full-year plan of 200 million yen was 5.5%, also falling below the same period of the previous year of 33.3%.
In the most recent three-month period, from January to March (1Q), the operating profit margin sharply declined from 15.5% in the same period last year to 3.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2023 | 1,167 | -155 | -242 | -243 | -5.6 | ー | May 12, 2023 | J-GAAP |
| Jan - Mar, 2024 | 1,377 | 214 | 229 | 472 | 9.4 | 43.4 | May 10, 2024 | J-GAAP |
| Jan - Mar, 2025 | 1,150 | 44 | 11 | 292 | 5.8 | ー | May 9, 2025 | J-GAAP |
| YoY | -16.5% | -79.4% | -95.2% | -38.1% | -38.0% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2024 | 2,860 | 482 | 528 | 764 | 15.2 | 0 | Aug 9, 2024 | J-GAAP |
| Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | - | Feb 13, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 6,120 | -1,005 | -1,248 | -3,611 | -76.3 | 0 | Feb 9, 2024 | J-GAAP |
| Dec, 2024 | 6,292 | 629 | 688 | 898 | 17.9 | 0 | Feb 13, 2025 | J-GAAP |
| Dec, 2025 Guidance | 6,300 | 215 | 200 | 300 | 6.0 | - | Feb 13, 2025 | J-GAAP |
| YoY | +0.1% | -65.8% | -70.9% | -66.6% | -66.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 1,377 | 214 | 229 | 472 | 9.4 | 15.5 | May 10, 2024 | J-GAAP |
| Apr - Jun, 2024 | 1,483 | 268 | 299 | 292 | 5.8 | 18.1 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 1,719 | 244 | 177 | -50 | -1.0 | 14.2 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 1,713 | -97 | -17 | 184 | 3.7 | -5.7 | Feb 13, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,150 | 44 | 11 | 292 | 5.8 | 3.8 | May 9, 2025 | J-GAAP |
| YoY | -16.5% | -79.4% | -95.2% | -38.1% | -38.0% |
Related Articles
Nippon Carbon, Jan-Mar (1Q) Ordinary Profit Decreases by 31%
MatsukiyoCocokara, 4% Increase in Ordinary Profit, Update Record High for Fifth Consecutive Term, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 2 yen
TENMA, 22% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
Shizuoka Financial, 16% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 12 yen
NAGAHORI, 15% Increase in Ordinary Profit for The Current Fiscal Year
Fuji Oil Company, Ordinary Profit/Loss Unexpectedly Turn to Loss for Last Fiscal Year, The Current Fiscal Year's Ordinary Loss to Widen
MEDICAL SYSTEM NET, 1% Increase in Ordinary Profit for The Current Fiscal Year
rakumo, Jan-Mar (1Q) Ordinary Profit Increases by 26%
SHIMANE BANK, Last Fiscal Year Ordinary Profit Revised Upward by 37%
KATO SANGYO, First Half Ordinary Profit Unexpectedly Revised Upward by 6%